Immune surveillance in glioblastoma: Role of the NKG2D system and novel cell-based therapeutic approaches
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Scandinavian journal of immunology : the official journal of the Scandinavian Society for Immunology(96), H. 2, S.e13201- - ISSN 0300-9475
In: Wiley, Oxford
- Klassifikation
-
Medizin, Gesundheit
- Ereignis
-
Veröffentlichung
- (wo)
-
Kiel
- (wer)
-
Universitätsbibliothek Kiel
- (wann)
-
2022
- Urheber
- URN
-
urn:nbn:de:gbv:8:3-2024-00278-9
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:51 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chitadze, Guranda
- Kabelitz, Dietrich
- Universitätsbibliothek Kiel
Entstanden
- 2022
Ähnliche Objekte (12)
Funtional evaluation of HMGB1 as immune therapeutic effector molecule for cell-based vaccination strategies
Functional evaluation of HMGB1 as immune therapeutic effector molecule for cell-based vaccination strategies
Advances in Cell-based Therapeutic Process Development
Therapeutic Potential of Selenium in Glioblastoma
SUMOylation in glioblastoma : a novel therapeutic target
The Use of Cell-based Approaches for Inducing Therapeutic Vascularization
Impact of innate and adaptive immune cells in tumor immune surveillance
EGFR and mTOR as therapeutic targets in glioblastoma
Dendritic cell- and T cell-based immune therapies against Ebola virus infection
Therapeutic measles virus and the immune system
Epigenetic neural glioblastoma enhances synaptic integration and predicts therapeutic vulnerability
Epigenetic neural glioblastoma enhances synaptic integration and predicts therapeutic vulnerability
Funtional evaluation of HMGB1 as immune therapeutic effector molecule for cell-based vaccination strategies
Functional evaluation of HMGB1 as immune therapeutic effector molecule for cell-based vaccination strategies
Advances in Cell-based Therapeutic Process Development
Therapeutic Potential of Selenium in Glioblastoma
SUMOylation in glioblastoma : a novel therapeutic target
The Use of Cell-based Approaches for Inducing Therapeutic Vascularization
Impact of innate and adaptive immune cells in tumor immune surveillance
EGFR and mTOR as therapeutic targets in glioblastoma
Dendritic cell- and T cell-based immune therapies against Ebola virus infection
Therapeutic measles virus and the immune system
Epigenetic neural glioblastoma enhances synaptic integration and predicts therapeutic vulnerability
Epigenetic neural glioblastoma enhances synaptic integration and predicts therapeutic vulnerability
Funtional evaluation of HMGB1 as immune therapeutic effector molecule for cell-based vaccination strategies
Functional evaluation of HMGB1 as immune therapeutic effector molecule for cell-based vaccination strategies
Advances in Cell-based Therapeutic Process Development
Therapeutic Potential of Selenium in Glioblastoma
SUMOylation in glioblastoma : a novel therapeutic target
The Use of Cell-based Approaches for Inducing Therapeutic Vascularization
Impact of innate and adaptive immune cells in tumor immune surveillance
EGFR and mTOR as therapeutic targets in glioblastoma
Dendritic cell- and T cell-based immune therapies against Ebola virus infection
Therapeutic measles virus and the immune system
Epigenetic neural glioblastoma enhances synaptic integration and predicts therapeutic vulnerability